Heterocyclic compounds for enhancing antitumor activity
US5583137A · kind A · utility
4Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 1994 |
| Grant date | Dec 10, 1996 |
| Priority date | — |
| Expiry date | Aug 17, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
2,6-Diaminopurines, 3,5-diamino-6,7,8,9-tetrahydrobenzo[b]thiophene[2,3-d]pyrimidines and 2,4-diaminothieno[3,2-d]pyrimidines useful as inhibitors of P-glycoproteins and potentiators of chemotherapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.